FCER2 and neoplasm: This entity could be a variant described in the WHO classification as ‘fibroblastic reticular cell tumor,’ histologically similar to follicular or interdigitating dendritic cell sarcoma, but lacks the immunophenotypic profile of these tumor types (CD21, CD23, or CD35 positivity).